YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Is the Use of Low Molecular Weight Heparin Sufficient in Patients Undergoing Total Knee Arthroplasty for 15 Days

dc.authorscopusid 58499235000
dc.authorscopusid 57828041600
dc.authorscopusid 58870392500
dc.authorscopusid 58871417600
dc.contributor.author Kaya, Ş.
dc.contributor.author Dündar, A.
dc.contributor.author Turgut, M.H.
dc.contributor.author Ünal, Y.C.
dc.date.accessioned 2025-05-10T16:55:19Z
dc.date.available 2025-05-10T16:55:19Z
dc.date.issued 2024
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp Kaya Ş., Department of Orthopaedics and Traumatology, Dursun Odabaş Medical Centre, Van Yuzuncu Yil University, Van, Turkey; Dündar A., Department of Orthopaedics and Traumatology, Faculty Of Medicine, Hittite University, Çorum, Turkey; Turgut M.H., Department of Orthopaedics and Traumatology, Dursun Odabaş Medical Centre, Van Yuzuncu Yil University, Van, Turkey; Ünal Y.C., Department of Orthopaedics and Traumatology, Dursun Odabaş Medical Centre, Van Yuzuncu Yil University, Van, Turkey en_US
dc.description.abstract Venous thromboembolic events, which can occur, if necessary, precautions are not taken after total joint arthroplasty, are a significant cause of mortality. One of the medical treatments used for prevention is low molecular weight heparin. Duration of low molecular weight heparin (LMWH) is used for prophylaxis can vary among physicians.In this study, we c ompared the effect of the duration of LMWH use on thromboembolic complications within patients, who had total knee arthroplasty. The study is retrospective and data is obtained from total of 224 adult patients over the age of 18. Age, gender, and thromboembolic complications were evaluated. The patients were separated into two groups as those who used LMWH for 15 days and those who used LMWH for 30 days and the development of thromboembolic complications between the two groups was compared statistically. Of the 224 patients thrown in the study, %81.7 were women. Group 1 (those who used LMWH for 15 days) consisted of 116 patients, and group 2 (those who used LMWH for 30 days) consisted of 108 patients. The distinction between the two groups regarding deep vein thrombosis (DVT) did not display any statistically significant difference (p=0.943). In DVT prophylaxis in patients undergoing total knee arthroplasty, LMWH for 15 days is as effective as LMWH for 30 days Therefore, it is sufficient to give LMWH for a short period of time as it is an invasive procedure. © 2024, Yuzuncu Yil Universitesi Tip Fakultesi. All rights reserved. en_US
dc.identifier.doi 10.5505/ejm.2024.53533
dc.identifier.endpage 69 en_US
dc.identifier.issn 1301-0883
dc.identifier.issue 1 en_US
dc.identifier.scopus 2-s2.0-85184456766
dc.identifier.scopusquality Q4
dc.identifier.startpage 66 en_US
dc.identifier.trdizinid 1248582
dc.identifier.uri https://doi.org/10.5505/ejm.2024.53533
dc.identifier.uri https://hdl.handle.net/20.500.14720/3456
dc.identifier.volume 29 en_US
dc.identifier.wosquality N/A
dc.language.iso en en_US
dc.publisher Yuzuncu Yil Universitesi Tip Fakultesi en_US
dc.relation.ispartof Eastern Journal of Medicine en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Dvt Prophylaxis en_US
dc.subject Low Molecular Weight Heparin en_US
dc.subject Total Knee Arthroplasty en_US
dc.title Is the Use of Low Molecular Weight Heparin Sufficient in Patients Undergoing Total Knee Arthroplasty for 15 Days en_US
dc.type Article en_US

Files